Keyphrases
Neurological Diseases
100%
N-methyl-D-aspartate Receptor Antibody
100%
Antibody-mediated
100%
Surveillance Studies
100%
Movement Disorders
42%
Encephalitis
42%
Pediatric
28%
Complete Recovery
28%
Second-line Immunotherapy
28%
Behavior Change
14%
Cognitive Decline
14%
Clinical Features
14%
One-child
14%
Seizure
14%
Management Outcome
14%
Neuropsychiatric Symptoms
14%
Neuropsychiatric Features
14%
Neurological Outcome
14%
Early Treatment
14%
Fisher's Exact Test
14%
Intravenous Immunoglobulin (IVIg)
14%
Plasma Exchange
14%
Encephalopathy
14%
Change Features
14%
Feature Management
14%
Seizure Disorder
14%
Late Diagnosis
14%
Prospective Surveillance
14%
Medicine and Dentistry
N Methyl-D-Aspartate Receptor
100%
Receptor Antibody
100%
Neurologic Disease
100%
Stereotypic Movement Disorder
42%
Encephalitis
42%
Epileptic Seizure
28%
Pediatrics
28%
Immunotherapy
28%
Immunoglobulin
14%
Clinical Feature
14%
Brain Disease
14%
Behavioral Change
14%
Fisher Exact Test
14%
Plasma Exchange
14%
Cognition
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Antibody
100%
Aspartic Acid
100%
Neurologic Disease
100%
Motor Dysfunction
42%
Encephalitis
42%
Immunotherapy
28%
Immunoglobulin
14%
Syndrome
14%
Clinical Feature
14%
Brain Disease
14%
Neuroscience
Nervous System Disorder
100%
Receptor Antibody
100%
Aspartic Acid
100%
Stereotypic Movement Disorder
42%
Encephalitis
42%
Immunotherapy
28%
Blood Plasma
14%
Intravenous Immunoglobulin
14%
Brain Disease
14%
Epilepsy
14%